Consistently, upregulation of CXCL12 and downregulation of CXCR7 were observed in temozolomide-resistant glioblastoma U87MG, A172, and Pt#3 cells, without consistent change in CXCR4 expression (Supplementary Fig. S3A). This evidence concerns the gene CXCR4 and glioblastoma.